Related Experiment Video
Updated: Sep 17, 2025
06:50
Author Spotlight: Bidirectional Mitochondrial Transfer between MSCs and Retinal Pigment Epithelium Cells — Pathways and In Vivo Challenges
Published on: October 4, 2024
1.0K
Mitochondrial transplantation: adaptive bio-enhancement
1Guangdong Provincial Key Laboratory of Proteomics, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China. fylxmgg@gmail.com.
Cell Death & Disease
|July 2, 2025
Summary
Transplanting mitochondria, the cell powerhouses, can treat diseases. This study shows donor species doesn't matter, but metabolic compatibility and mitochondrial activity are key for therapeutic benefits.
Area of Science:
- Cell Biology
- Mitochondrial Medicine
- Bioenergetics
Background:
- Mitochondria are vital for cellular energy production; dysfunction impacts organs.
- Mitochondrial transplantation shows promise for treating diseases by restoring bioenergetics.
Purpose of the Study:
- To explore the potential of mitochondrial transplantation as a therapeutic strategy.
- To identify factors influencing the efficacy of transplanted mitochondria.
Main Methods:
- Investigated the impact of germline origin on transplanted mitochondria.
- Assessed metabolic compatibility between recipient cells and exogenous mitochondria.
- Analyzed competitive interactions between mitochondria with different bioenergetic activities.
Main Results:
- Transplanted mitochondria efficacy is independent of donor species or germline.
- Metabolic compatibility is crucial for conferring therapeutic properties.
- Highly bioenergetic-active mitochondria provide superior therapeutic benefits.
- No identified upper limit for bioenhancement through mitochondrial transplantation.
Conclusions:
- Mitochondrial transplantation is a versatile therapeutic approach.
- Metabolic compatibility and mitochondrial activity are critical determinants of success.
- Adaptive bioenhancement via mitochondrial transplantation offers a novel therapeutic avenue.
Related Concept Videos
01:46Electron Transport Chain: Complex I and II
15.1K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.1K
02:59Animal Mitochondrial Genetics
8.1K
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
8.1K
01:24Tissue Transplantation
524
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
524